FundingHealthcare & Life Sciences
eNLife Research raises ₹6 crore seed funding
By Abha Lohia · Editor ·
seedBengaluruFounded 2025
- ENLife Research uses AI to detect Alzheimer's and neurodegenerative disorders through blood biomarkers
- It raised ₹6 crore in seed funding led by Piper Serica VC Fund
- The platform is tailored to Indian genetic profiles, addressing a gap in existing diagnostic models
What happened
- eNLife Research has raised ₹6 crore in seed funding.
- The round was led by Piper Serica VC Fund.
- The company is developing an AI-powered blood biomarker platform for early detection of Alzheimer's and neurodegenerative disorders.
- The platform can detect signs up to 15 years before clinical symptoms appear.
- It screens 5-7 biomarkers including amyloid beta and abnormal tau through a blood test.
- Results are delivered within 2-5 hours through routine diagnostic centres.
- The company plans to expand its R&D team in Bengaluru and advance its first diagnostic assay to clinical-grade.
Why it matters
- Existing diagnostic models are developed on Western populations and are not accurate for Indian patients due to genetic and lifestyle differences.
- India is expected to have the fastest-growing ageing population, making early diagnosis critical.
- Conventional methods like PET scans, MRI scans, and cerebrospinal fluid analysis are expensive, invasive, and used late.
The business
- Its blood test screens 5-7 biomarkers including amyloid beta and abnormal tau.
- Next-generation assays will track 25-100 biomarkers for multiple dementias and neurodegenerative disorders.
- Results are available within 2-5 hours through routine diagnostic centres.
- The AI engine is trained on Indian population data, tailored to Indian genetic and lifestyle risk profiles.
- The company collaborates with IISc, NIMHANS, TIFR Hyderabad, and Centre for Brain Research (CBR) Bengaluru.
- It was incubated at FSID, Indian Institute of Science (IISc).
- Headquarters are in Bengaluru, and the company was founded in 2025.
The founders
DD
Dr. Deepak Kumaran Nair
co-founder & CEO- Professor at Centre for Neuroscience, IISc.
- Co-founder and CEO of eNLife Research.
LC
Lt. Col. Jojo Jacob
co-founder- A veteran.
AM
Anish Mathew
co-founder- Former CEO of CAMS Finserv, a CAMS Group subsidiary.
Who put in money
- Piper Serica VC Fund lead — Piper Serica's Bharat Tech Fund is ₹800 crore and backs AI, biosciences, semiconductors, defence tech, spacetech, and cybersecurity. Its director is Rajni Agarwal.
In numbers
₹6 croreseed funding raised · 2026
5-7biomarkers screened in current test · 2026
25-100biomarkers tracked in next-gen assays · 2026
15years before symptoms detection possible · 2026
2-5 hourstime to results · 2026
What happens next
- Expand the R&D team in Bengaluru.
- Validate the biomarker platform.
- Advance the first diagnostic assay from prototype to clinical-grade.
- Begin patent filing within 9-18 months covering biomarker binders, diagnostic assays, and detection platform.
Words to know
- biomarker
- A biological molecule found in blood or other body fluids that indicates a normal or abnormal process, or a disease.
- amyloid beta
- A protein that forms plaques in the brain, associated with Alzheimer's disease.
- tau
- A protein that forms tangles in the brain, another hallmark of Alzheimer's disease.
- seed funding
- Early-stage investment to help a startup develop its product or service before generating revenue.
The numbers around it
Healthcare & Life Sciences in July 2026: 11 rounds with a disclosed amount, $87.1 million in all; the biggest was Iswarya (Rs 350 crore). Every sector this year →
Other articles talking about it
indian-startup-times ↗Indian Startup Times ↗indianpharmapost ↗whalesbook ↗Indian Startup News ↗Entrackr ↗biospectrumindia ↗
Terms in this story
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 8 July 2026 →
Is this eNLife Research? Get your “Featured on StopDown” badge →